Research
Excludes commercial-in-confidence projects.
Characterising an RNA splicing pathway driving prostate cancer metastasis and therapy resistance, NHMRC - Project Grant, 01/01/2019 - 31/12/2022
Discovering how microRNAs and circRNAs control cancer metastasis, NHMRC - Research Fellowship, 01/01/2017 - 31/12/2021
Use of a new molecule (miR-342) to discover important pathways to treat advanced breast cancer, NBCF - Investigator Initiated Research Scheme, 01/01/2018 - 01/07/2021
Develop efficient data mining methods for evidence based decision making, ARC - Discovery Projects, 29/06/2017 - 28/06/2021
Characterising novel alternative splicing networks that promote tumour cell plasticity, NHMRC - Project Grant, 01/01/2017 - 31/12/2019
Functions of circular RNAs, NHMRC - Project Grant, 01/01/2017 - 31/12/2019
Using miR-200 to find new therapeutic targets for neuroblastoma, NHMRC - Project Grant, 01/01/2017 - 31/12/2019
Cancer Discovery Accelerator, Australian Cancer Research Foundation, 01/06/2016 - 31/07/2018
Formation and function of circular RNAs in human cells, NHMRC - Project Grant, 01/01/2015 - 31/12/2017
Targeting microRNA-driven mesenchymal to epithelial transition to suppress prostate cancer metastasis, NHMRC - Project Grant, 01/01/2015 - 31/12/2017
Do circular RNAs affect breast cancer progression?, National Breast Cancer Foundation - Innovator Grant, 01/01/2016 - 31/12/2017
Role of the microRNA target Quaking in alternative splicing during EMT and cancer progression, NHMRC - Project Grant, 01/01/2014 - 31/12/2017
Cancer Discovery Accelerator, Cancer Council SA - Beat Cancer, 08/06/2016 - 08/06/2017
MicroRNAs and cancer metastasis, NHMRC - Research Fellowship, 01/01/2014 - 31/12/2016
How isomiRs expand the microRNA functional repertoire in affecting gene expression, NHMRC - Project Grant, 01/01/2014 - 31/12/2016
miR-200 and its targets as inhibitors of neuroblastoma growth and metastasis, Channel 7 Children's Research Foundation of SA, 01/01/2015 - 31/12/2016
Research
Research outputs for the last seven years are shown below. To see earlier years visit ORCID
Open access indicates that an output is open access.
Year | Output |
---|---|
2018 |
14
1
|
Year | Output |
---|---|
2022 |
10
9
3
|
2022 |
Open access
8
5
|
2022 |
Open access
4
4
|
2021 |
Open access
18
18
126
|
2021 |
Goodall, GJ & Wickramasinghe, VO 2021, 'RNA in cancer', Nature Reviews Cancer, vol. 21, pp. 22-36.
Open access
454
453
48
|
2021 |
Open access
7
8
13
|
2021 |
Open access
2
2
1
|
2021 |
Open access
10
9
8
|
2021 |
Open access
1
1
2
|
2020 |
Open access
2
3
1
|
2020 |
Open access
4
4
39
|
2020 |
Open access
6
6
9
|
2020 |
Open access
690
673
115
|
2019 |
Open access
13
14
5
|
2019 |
Open access
10
9
1
|
2019 |
Open access
5
4
4
|
2019 |
9
11
1
|
2019 |
Open access
79
74
11
|
2018 |
Open access
82
79
2
|
2018 |
Open access
18
4
|
2018 |
Open access
58
54
34
|
2018 |
Open access
23
21
2
|
2018 |
Open access
13
13
1
|
2018 |
Open access
56
56
15
|
2018 |
Open access
34
33
4
|
2017 |
Open access
82
82
61
|
2017 |
37
37
1
|
2017 |
Open access
84
83
11
|
2017 |
Open access
52
49
7
|
2016 |
Open access
483
479
32
|
2015 |
49
45
12
|
2015 |
Open access
49
49
1
|
2015 |
Open access
1324
1320
21
|
2015 |
Open access
25
23
4
|
2015 |
Open access
32
31
5
|
2015 |
Open access
26
24
2
|
2015 |
Open access
48
47
5
|
2014 |
Open access
44
44
3
|
2014 |
Open access
115
114
13
|
2014 |
45
43
1
|
2014 |
Open access
53
49
|
2014 |
Open access
24
23
|
2014 |
43
55
|
2014 |
Open access
17
15
3
|
2013 |
Open access
18
17
4
|
2013 |
Open access
162
149
1
|
2013 |
Open access
132
124
4
|
2013 |
Open access
143
133
|
2013 |
Open access
89
87
|
2012 |
Open access
129
127
11
|
2012 |
351
335
17
|
2011 |
Open access
64
62
|
2011 |
Open access
445
420
|
2011 |
Open access
118
115
|
2011 |
Open access
447
417
|
2011 |
Open access
166
154
|
2010 |
95
93
|
2010 |
Open access
70
60
|
2010 |
Open access
105
105
|
2009 |
106
94
|
2009 |
29
28
|
2009 |
Open access
402
386
|
2009 |
52
49
|
2008 |
Open access
879
831
|
2008 |
3174
3004
|
2008 |
Open access
421
391
|
2008 |
Open access
73
69
|
External engagement & recognition
Organisation | Country |
---|---|
Australian National University | AUSTRALIA |
Bar-Ilan University | ISRAEL |
Baylor College of Medicine | UNITED STATES |
Canberra Hospital | AUSTRALIA |
Cancer Council of South Australia | AUSTRALIA |
Central Queensland University | AUSTRALIA |
Charles Sturt University | AUSTRALIA |
Children's Cancer Institute Australia | AUSTRALIA |
Childrens Hospital at Westmead | AUSTRALIA |
Dali University | CHINA |
Deakin University | AUSTRALIA |
Flinders University | AUSTRALIA |
Garvan Institute of Medical Research | AUSTRALIA |
Ghent University | BELGIUM |
Hanson Institute | AUSTRALIA |
Harvard University | UNITED STATES |
Hudson Institute of Medical Research | AUSTRALIA |
Institute of Medical and Veterinary Science | AUSTRALIA |
Istituto di Ricerche Farmacologiche Mario Negri | ITALY |
Kanazawa University | JAPAN |
Kumamoto University | JAPAN |
Kunming University of Science and Technology | CHINA |
Mahidol University | THAILAND |
Monash University | AUSTRALIA |
Monterrey Institute Of Technology And Higher Education | MEXICO |
Nagasaki University | JAPAN |
National University of Singapore | SINGAPORE |
Peter MacCallum Cancer Centre | AUSTRALIA |
QIMR Berghofer Medical Research Institut | AUSTRALIA |
Queen Elizabeth Hospital | AUSTRALIA |
Queensland University of Technology | AUSTRALIA |
Royal Children's Hospital | UNITED KINGDOM |
SA Pathology | AUSTRALIA |
Shanghai Jiao Tong University | CHINA |
South Australian Health and Medical Research Institute (SAHMRI) | AUSTRALIA |
St Vincent's Hospital | AUSTRALIA |
Stanford University | UNITED STATES |
The Institut Pasteur | FRANCE |
Université Laval | CANADA |
University Libre Bruxelles | BELGIUM |
University of Adelaide | AUSTRALIA |
University of Arizona | UNITED STATES |
University of British Columbia | CANADA |
University of California | UNITED STATES |
University of Canberra | AUSTRALIA |
University of Malaya | MALAYSIA |
University of Melbourne | AUSTRALIA |
University of New South Wales | AUSTRALIA |
University of Newcastle | AUSTRALIA |
University of North Carolina at Chapel Hill | UNITED STATES |
University Of Oklahoma Norman | UNITED STATES |
University of Pennsylvania | UNITED STATES |
University of Queensland | AUSTRALIA |
University of South Australia | AUSTRALIA |
University of Surrey | UNITED KINGDOM |
University of Sydney | AUSTRALIA |
University of Texas | UNITED STATES |
University of Texas MD Anderson Cancer Centre | UNITED STATES |
Walter and Eliza Hall Institute of Medical Research | AUSTRALIA |
Women's and Children's Hospital | AUSTRALIA |
External engagement & recognition
Engagement/recognition | Year |
---|---|
FellowAustralian Academy of Science |
2018 |
Julian Wells MedalLorne Genome Conference |
2018 |
Project GrantNational Health and Medical Research Council (NHMRC) |
2016 |
FellowAustralian Academy of Health and Medical Science |
2015 |
Teaching & student supervision
Supervisions from 2010 shown
Thesis title | Student status |
---|---|
110423 - Tackling Neuroblastoma using a multi-omics bioinformatics approach | Current |
A novel protein ZCCHC24 as a regulator of breast cancer cell plasticity and metastasis | Current |
Alternative splicing networks and their impact on the development of aggressive prostate cancer | Current |
Nuclear functions of microRNAs that control EMT in breast cancer | Current |
Targeting oncogenic signalling with custom RNA drugs | Current |
Understanding how the epigenetic field effect exerted by cancers upon their microenvironment promotes tumour progression | Current |
Understanding how the epigenetic field effect exerted by cancers upon their microenvironment promotes tumour progression | Current |
Computational modelling for breast cancer prognosis in precision medicine | Completed |
Developing network inference methods for cancer driver discovery | Completed |
Elucidating coding region targets of microRNAs | Completed |
The role of RNA-binding proteins in epithelial-mesenchymal transition | Completed |